References with PepMix™ Peptide Pools

References with PepMix™ Peptide Pools - Control Pools

2024

MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
Mayer et al., Vaccines (2024) - PMID: 38278816
Products used: CEF Pool (extended), PepMix™ SARS-CoV-2 (Spike Glycoprotein)
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Pant et al., Nature Medicine (2024) - PMID: 38195752
Products used: PepMix SARS-CoV-2 (S-RBD), CEFSX Ultra SuperStim Pool, CEFT Pool, PepMix™ Pan-CMV Select, PepMix CMVA pp65, PepMix™ Pan-EBV Select, CEF Pool (standard)
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient
Boschert et al., Science Advances (2024) - PMID: 38306431
Products used: CEFX Ultra SuperStim Pool
Impaired T and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation
Lauruschkat et al., Blood Advances (2024) - PMID: 38315873
Products used: PepMix™ CMVA (pp65), PepMix™ HIV-1 (NEF) Ultra

2023

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Pant et al., Nature Medicine (2024) - PMID: 38195752
Product used: PepMix™ SARS-CoV-2 (S-RBD), CEFSX Ultra SuperStim Pool, CEFT Pool, PepMix™ Pan-CMV Select, PepMix CMVA pp65, PepMix™ Pan-EBV Select, CEF Pool (standard)
Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapy
Sweeney et al., Bionengineering and Translational Medicine
Product used: PepMix™ Human (Actin)
Charakterisierung von T-Stammzell-Gedächtnis Zellen (TSCM) in verschiedenen Alterkohorten Characterization of T Stem Cell Memory Cells in distinct Age bands
Hasselmann, Dissertation (2023)
Products used: PepMix™ CMVA (pp65), PepMix™ CMVA (IE-1)
A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy
Kirkland et al., Antimicrobial Agents and Chemotherapy
Product used: CEFT Pool, PepMix™ Human (MOG)
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A*03 and HLA-B*15 via peptide-PRISM
Rein et al., Blood Advances (2023)
Product used: PepMix™ CMVA (pp65)
Cytomegalovirus-Specific T Cells in Pediatric Liver Transplant Recipients
Getsuwan et al., Viruses (2023)
Products used: PepMix CMVA (IE-1), PepMix CMVA (pp65)
Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target
Mandal et al., Nature Cancer (2023)
Products used: PepMix EBV (LMP1), EBV (EBNA1), EBV (LMP2), EBV (BZLF1), EBV (BRLF1), PepMix CMVA (pp65), PepMix CMVA (IE-1)
Identification and validation of neoepitope-specific T cell receptors for glioma immunotherapy
Lindner, Dissertation (2023)
Product used: CEF Pool (standard)
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
Palmer et al., Nature Medicine (2023) - PMID: 35970920
Product used: CEF Pool (standard)
Identifizierung und Charakterisierung antigenspezifischer T-Zell-Antworten gegen Glioblastome
Lu, Dissertation (2023)
Products used: human TAAs & CEF Pool (standard)
Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report
Hoff et al., Therapeutic Advances in Hematology (2023) - PMID: 37822572
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians
Rakshit et al., NPJ Vaccines (2023) - PMID: 37709772
Product used: CEFT Pool
U54 SCENT Intracellular Staining (ICS) Senescence Flow Cytometry Panel
Healy et al., Scent, Protocol
Products used: CEF Pool (extended), CEFX Ultra SuperStim Pool
Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study
Voong et al., Journal for ImmunoTherapy of Cancer (2023)
Products used: CEFX Ultra SuperStim Pool MHC-II Subset & PepMix™ HIV-1 (GAG) Ultra
Activating Inducible T cell Co-stimulator (ICOS) yields anti-tumor activity alone and in combination with anti-PD-1 checkpoint blockade
Yadavilli et al., AACR Journals (2023)
Products used: CEFT Pool
Exercise mobilizes diverse antigen specific T-cells and elevates neutralizing antibodies in humans with natural immunity to SARS CoV-2
Baker et al., Brain Behaviour & Immunity (2023) - PMID: 36743994
Products used: PepMix Human (Actin) & SARS-CoV-2 (Spike Glycoprotein)
CD40 ligand stimulation affects the number and memory phenotypes of human peripheral CD8+ T cells
Choi et al., BMC Immunology (2023) - PMID: 37391734
Product used: PepMix CMVA (pp65)
GRT-R910: a self-amplifying mRNA SARSCoV-2 vaccine boosts immunity for ≥6months in previously-vaccinated older adults
Palmer et al., Nature Communications (2023) - PMID: 37280238
Product used: CEF Pool (standard)
Antigen specificities of HIV-infected cells: A role in infection and persistence?
Faua et al., Journal of Virus Eradication (2023)
Product used: CEFT MHC-II Pool & PepMix CMVA (pp65)
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients
Friedrich et al., Cancer Cell (2023) - PMID: 36898378
Product used: CEFT Pool
Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients
Fernández‐Ruiz et al., Journal of Medical Virology (2023)
Product used: PepMix HCMVA (pp65)
Untersuchungen zur Kreuzreaktivität von Cytomegalievirusspezifischen T-Lymphozyten und Tumorassoziierten Antigenen
Weiß, Dissertation (2023)
Products used: PepMix CMVA (pp65), Human (Mucin-1), Human (NY-ESO-1), Human (Prame/OIP4) & Human (WT1/WT33)
Validation of the performance and suitability of a new class of FBS optimized for use in single-cell functional assays
Berrong et al., Journal of Immunological Methods (2023) - PMID: 36858170
Product used: CEF Pool (extended), CEFT MHC-II Pool & PepMix™ CMVA (pp65)
Cardiac antigen derived T cell epitopes in the frame of myocardial infarction
Hapke et al., Dissertation (2023)
Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens
Morhart et al,. In Vivo (2023)
Products used: PepMix CEFX Ultra SuperStim Pool & PepMix Human (Actin)
Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune modifying therapies
Klebanoff et al., MedRxiv (2023)
Products used: CEFX Ultra SuperStim Pool & PepMix SARS-CoV-2 (Spike Glycoprotein)

Archive

Filaggrin insufficiency renders keratinocyte-derived small extracellular vesicles capable of modulating CD1a-mediated T cell responses
Kobiela et al., Research Square (2022)
Product used: CEFT Pool
Immune Response after the Fourth of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients
Busà et al,. Vaccines (2022) - PMID: 36298854
Products used: PepMix SARS-CoV-2 (Spike Glycoprotein), SARS-CoV-2 (NCAP) and CEFX Ultra SuperStim Pool
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
Awad et al., Cancer Cell (2022) - PMID: 36027916
Product used: PepMix CEF Pool (extended)
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
Palmer et al., Nature Medicine (2022)
Product used: PepMix CEF Pool (standard)
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine
Naaber et al., Cell Reports Medicine (2022)
Product used: PepMix CEFX Ultra Super Stim Pool
Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination
Sistere-Oro et al., Frontiers in Immunology (2022)
Product used: PepMix CEF Pool Standard
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
Weskamm et al., Cell Reports Medicine (2022) - PMID: 35858586
Product used: PepMix CEF Pool (extended)
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study
Tut et al., The Lancet (2022)
Product used: PepMix CEFX Ultra SuperStim Pool
An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
Fucikova et al., Clinical Cancer Research (2022) - PMID: 35536547
Product used: PepMix CEFT Pool
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency
Campbell et al., Journal of Experimental Medicine (2022) - PMID: 35670811
Products used: PepMix CEFX Ultra SuperStim Pool, PepMix CMVA (IE-1 , IE-2 & pp65),
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
Tut et al., Nature Aging (2022)
Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases
Sudmeier et al., Cell Reports Medicine (2022)
Product used: PepMix CEFX Ultra SuperStim Pool
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
Oliveira et al., Nature (2022) - PMID: 35508657
Protective antibodies and T cell responses to Omicron variant three months after the booster dose of BNT162b2 vaccine
Naaber et al., MedRxiv (2022)
Product used: CEFX Ultra SuperStim Pool
Broad SARS-CoV-2 spike-specific CD4+ T-cell response preserves recognition of variants of concern
Long et al., Research Square (2022)
Product used: CEFX Ultra SuperStim Pool MHC-II Subset
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
Rodda et al., MedRxiv (2022)
Products used: CEFX Ultra SuperStim Pool
A Co-stimulatory CAR Improves TCR-based Cancer Immunotherapy
Omer et al., Cancer Immunology (2022) - PMID: 35176142
Development of an effective immune response in adults with Down Syndrome 2 after SARS-CoV-2 vaccination
Esparcia-Pinedo et al., MedRxiv (2022)
Products used: PepMix™ Human (Actin)
T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option
Sibylle C.Mellinghoff et al., MedRxiv (2021) - PMID: 34921845
TGM4: An Immunogenic Prostate-Restricted Antigen
Lopez-Bujanda, Z.A. et al., J Immunother Cancer (2021)
Anti-CD38 Therapy Impairs SARS-CoV-2 Vaccine Response in Multiple Myeloma Patients
S. Henriquez et al., medRxiv, (2021)
Acute Exercise Increases Immune Responses to SARS CoV-2 in a Previously Infected Man
Baker, F.L. et al., Brain Behav Immun Health (2021)
Dynamics of Antibody Response to BNT162b2 Vaccine After Six Months: a Longitudinal Prospective Study
Naaber, Paul et al., Lancet Reg Health Eur, (2021)
Identification of a Class of Non-Conventional ER-Stress-Response-Derived Immunogenic Peptides
Melacarne, Alessia et al., Cell Rep, (2021)
Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma
Rennert, Charlotte et al., Cells, (2021)
Monitoring Cell-Mediated Immune Responses in AAV Gene Therapy Clinical Trials Using a Validated IFN-γ ELISpot Method
Patton, K.S. et al., Mol Ther Methods Clin Dev, (2021)
Gene Transfer in Adeno-Associated Virus Seropositive Rhesus Macaques Following Rapamycin Treatment and Subcutaneous Delivery of AAV6, but Not Retargeted AAV6 Vectors
Stone, Daniel et al., Human Gene Ther, (2021)
Identification of Neoantigen-Reactive T Lymphocytes in the Peripheral Blood of a Patient With Glioblastoma
Leko, V. et al., J Immunother Cancer, (2021)
Circulatory Follicular Helper T Lymphocytes Associate With Lower Incidence of CMV Infection in Kidney Transplant Recipients
Suàrez-Fernández, P. et al., Am J Transplant, (2021)
A Glimpse into the Diverse Cellular Immunity Against SARS-CoV-2
Chang, Cheng-Wei et al., Vacinnes, (2021)
Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination
Harrison, Nicole et al., Vaccines, (2021)
HIV-Specific T Cell Responses Reflect Substantive in Vivo Interactions With Antigen Despite Long-Term Therapy
Stevenson, E.M. et al., JCI Insight, (2021)
Identification of Naturally Processed Zika Virus Peptides by Mass Spectrometry and Validation of Memory T Cell Recall Responses in Zika Convalescent Subjects
Crooke, S.N. et al., PLoS One, (2021)
Pre-Transplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: a Prospective Cohort Study
Mohammed Altaf et al., J Infect Dis. (2020) - PMID: 33274385
Gating Harmonization Guidelines for Intracellular Cytokine Staining Validated in Second International Multiconsortia Proficiency Panel Conducted by Cancer Immunotherapy Consortium (CIC/CRI)
Leah S. Price et al., Journal of Quantitative Cell Science (2020) - PMID: 33090656
Microwave Ablation Enhances Tumor‑Specific Immune Response In Patients With Hepatocellular Carcinoma
Katharina Leuchte et al., Cancer Immunology, Immunotherapy (2020) - PMID: 33006650
A Glimpse Into the Diverse Cellular Immunity Against SARS-CoV-2
Lung-Ji Chang et al., Research Square (2020) - PMID: n.a.
Safety and Immunogenicity of a Modified Vaccinia Virus Ankara Vector Vaccine Candidate for Middle East Respiratory Syndrome: an Open-Label, Phase 1 Trial
Koch et al., Lancet (2020) - PMID: 32325037
Concurrent Human Antibody and TH1 Type T-Cell Responses 2 Elicited by a COVID-19 RNA Vaccine
Sahin et al., medRXiv (2020)
Safety and Immunogenicity Of a Modified Vaccinia Virus Ankara Vector Vaccine Candidate For Middle East Respiratory Syndrome: An Open-Label, Phase 1 Trial
Till Koch et al., The Lancet Infectious Diseases (2020) - PMID: 32325037
CMV-Reactive NK Cells in Pediatric Post-Hematopoietic Stem Cell Transplant
Nopporn Apiwattanakul et al., Transplantation Proceedings (2020) - PMID: 31870602
Magnitude and Functional Profile of the Human CD4+ T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus Vaccine
Renata Varnaite et al., The Journal of Immunology (2020) - PMID: 31924650
Antigen Responsive CD4+T Cell Clones Contribute to the HIV-1 Latent Reservoir
Pilar Mendoza et al., bioRxiv (2020) - PMID: n.a.
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms
Cansu Cimen Bozkus et al., Cancer Discovery (2019) - PMID: 31266769
Antigenspezifische T-Lymphozytenantworten als Immunmarker in Verschiedenen Varianten der Chronisch Inflammatorisch Demyelinsierenden Polyneuropathie
Jan Markus Diederich et al., Klinik für Neurologie mit Experimenteller Neurologie (2019) - PMID: n.a.
CD154‐Expressing CMV‐Specific T Cells Associate with Freedom from DNAemia and May be Protective in Seronegative Recipients After Liver or Intestine Transplantation
Chethan Ashokkumar et al., Wiley (2019) - PMID: n.a.
Extracellular pH Modulating Injectable Gel for Enhancing Immune Checkpoint Inhibitor Therapy
Hyung-seung Jin et al., Journal of Controlled Release (2019) - PMID: 31669264
CD38 bright CD8+ T-cells Associated with the Development of Acute GVHD are Activated, Proliferating, and Cytotoxic Trafficking Cells
Pooja Khandelwal et al., Biology of Blood and Marrow Transplantation (2019) - PMID: 31442594
Qualification of an IFN-g Elispot Assay in the Bioanalytical Laborator
W. Adamowicz et al., Poster#W1130-04-02 (2019) - PMID: n.a.
CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis
Kuerten et al., United States Patent Application 20190072551 (2019) - PMID: n.a.
Leukoreduction System Chambers are a Reliable Cellular Source for the
Manufacturing of T‐Cell Therapeutics
Gabrielle Boudreau et al., Transfusion (2018) - PMID: 30589447
Semi-Static Cell Culture
Molleryd et al., US Patent App. 15/574,003 (2018) - PMID: n.a.
Bi-Specific Targeted Chimeric Antigen Receptor T Cells
Wang et al., US Patent App. 15/561,921, 2018 (2018) - PMID: n.a.
Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity throughout Life
Miron et al., J Immunol (2018) - PMID: 30111633
Reversibility of Peripheral Blood Leukocyte Phenotypic and Functional Changes after Exposure to and Withdrawal from Tofacitinib, a Janus Kinase Inhibitor, in Healthy Volunteers
Weinhold et al., Clin. Immunol (2018) - PMID: 29518577
Human Cytomegalovirus-Specific Memory CD4+ T-cell Response and its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection
Fornara et al., J Infect Dis. (2017) - PMID: 17330798
The Effect of Genetic Variants Affecting NK Cell Function on Cardiovascular Health and the Burden on CMV
Waters S et al., Hum Immunol (2017) - PMID: 28987961
Intradermal HIV-1 DNA Immunization Using Needle-free Zetajet TM Injection Followed by HIV-modified Vaccinia Virus Ankara Vaccination is Safe and Immunogenic in Mozambican Young Adults: a Phase I Randomized Controlled Trial
Viegas et al., AIDS Res Hum Retroviruses (2017) - PMID: 28969431
CMV Drives the Expansion of Highly Functional Memory T Cells Expressing NK-Cell Receptors in Renal Transplant Recipients
Makwana et al., European Journal of Immunology (2017) - PMID: 28586095
CMV Specific T-Cell Immunity in Solid Organ Transplant Recipients at Low Risk of CMV Infection. Chronology and Aplicability in Preemptive Therapy
Mena-Romo et al., Journal of Infection (2017) - PMID: 28599954
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Tsai et al., Journal of Virology (2017) - PMID: 28179531
Generation of Dendritic Cell-based Vaccine Using High Hydrostatic Pressure for Non-small Cell Lung Cancer Immunotherapy
Hradilova et al., Plos One (2017) - PMID: 28187172
Phase II Trial of Albumin-Bound Paclitaxel and Granulocyte Macrophage Colony-Stimulating Factor as an Immune Modulator in Recurrent Platinum Resistant Ovarian Cancer
Liaoa et al., Gynecologic Oncology (2017) - PMID: 28089377
Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
Hui et al., Cancer Research (2016) - PMID: 23348421
Individuals with Inherited Chromosomally Integrated Human Herpes Virus 6 (ciHHV-6) Have Functionally Active HHV-6 Specific T-cell Immunity
Strenger et al., Clinical Microbiology and Infection (2016) - PMID: 26482270
Human Parainfluenza Virus-3 Can be Targeted by Rapidly Ex Vivo Expanded T Lymphocytes
McLaughlin et al., Cytotherapy (2016) - PMID: 27692559
A Fully Human IgG1 Anti-PD-L1 MAb in an In Vitro Assay Enhances Antigen-Specific T-Cell Responses
Grenga et al., Clinical & Translational Immunology (2016) - PMID: n.a.
Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
Navarro et al., Oxford Jounals (2016) - PMID: n.a.
Stoke Induces Specific Alteration of T Memory Compartment Controlling Auto-Reactive CNS Antigen-Specific T Cell Responses
Klehmet et al., Journal of the Neurological (2016) - PMID: n.a.
Stabilization of Pre‐optimized Multicolor Antibody Cocktails for Flow Cytometry Applications
Chan et al., Cytometry Part B: Clinical Cytometry (2016) - PMID: 27001933
How Frequently Are Predicted Peptides Actually Recognized by CD8 Cells?
Moldovan et al., Cancer Immunol Immunother. (2016) - PMID: 27108305
RNA Vaccination Therapy: Advances in an Emerging Field
Thielemans et al., Journal of Immunology Research (2016) - PMID: n.a.
Impact of Persistent Cytomegalovirus Infection on Dynamic Changes in Human Immune System Profile
Vescovini et al., PlosOne - PMID: 26990192
Standardization of Cryopreserved Peripheral Blood Mononuclear Cells Through a Resting Process for Clinical Immunomonitoring—Development of an Algorithm
Wang et al., Cytometry A. (2015) - PMID: 26848928
Dichotomous Effects of Latent CMV Infection on the Phenotype and Functional Properties of CD8+ T-cells and NK-cells
Bigley et al., Cellular Immunology (2015) - PMID: n.a
Combined PI3K/Akt and Hsp90 Targeting Synergistically Suppresses Essential Functions of Alloreactive T Cells and Increases Tregs
Berges et al., J. Leukoc. Biol. (2015) - PMID: 26265781
K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In Vivo
Caruana et al., Clin Cancer Res. (2015) - PMID: 25691731
Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients
Xu et al., Am J Transplant. (2015) - PMID: 26436448
Latent CMV Infection in Rheumatoid Arthritis Increases Frequencies of cytolytic LIR‐1+ CD8+ T Cells
Rothe et al., Arthritis Rheumatol. (2015) - PMID: 26314621
Self-adjuvanted mRNA Vaccination in Advanced Prostate Cancer Patients: a First-in-Man Phase I/IIa Study
Kübler et al., J Immunother Cancer. (2015) - PMID: 26082837
Guidelines For the Automated Evaluation of Elispot Assays
Janetzki et al., Nature Protocols (2015) - PMID: 26110715
The Transcriptional PPARβ/ Network in Human Macrophages Defines a Unique Agonist-induced Activation State
Adhikary et al., Nucleic Acids Res.(2015) - PMID: 25934804
Development of a Novel IGRA Assay to Test T Cell Responsiveness to HBV Antigens in Whole Blood of Chronic Hepatitis B Patients
Dammermann et al., J Transl Med. (2015) - PMID: 25968473
Profiling T Cell Activation Using Single-Molecule Fluorescence In Situ Hybridization and Flow Cytometry
Bushkin et al., J. Immunol. (2015) - PMID: 25505292
Identification and HLA-Tetramer-Validation of Human [CD4.sup.+] and [CD8.sup.+] T Cell Responses Against HCMV Proteins IE1 and IE2
Peter Braendstrup et al., PLoS ONE (2014) - PMID: 24760079
Cognate CD4 T-Cell Licensing of Dendritic Cells Heralds Anti-CMV CD8 T-Cell Immunity After Human Allogeneic Umbilical Cord Blood Transplantation
Flinsenberg et al., J Virol. (2014) - PMID: 25378489
T-bet:Eomes Balance, Effector Function, and Proliferation of Cytomegalovirus-specific CD8+ T Cells During Primary Infection Differentiates the Capacity for Durable Immune Control
Popescu et al., J Immunol. (2014) - PMID: 25339676
Polyfunctional Analysis of Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ Memory T-Cells in HCMV-Seropositive Healthy Subjects Following Different Stimuli
Gabanti et al., J Clin Immunol. (2014) - PMID: 25231588
Toward Development of a Comprehensive External Quality Assurance Program for Polyfunctional Intracellular Cytokine Staining Assays
Staats et al., J Immunol Methods. (2014) - PMID: 24968072
Viral Load, CMV-Specific T Cell Immune Response and Cytomegalovirus Disease in Solid Organ Transplant Recipients at Higher Risk for Cytomegalovirus Infection During Preemptive Therapy
Martín-Gandul et al., Transpl Int. (2014) - PMID: 24964364
A Registry of HLA-Typed Donors for Production of Virus-Specific CD4 and CD8 T Lymphocytes for Adoptive Reconstitution of Immune-compromised Patients
Pira et al., Transfusion. (2014) - PMID: 25041366
Frequent Occurrence of Cytomegalovirus Retinitis During Immune Reconstitution Warrants Regular Ophthalmic Screening in High-Risk Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients
Hiwarkar et al., Clinical Infectious Diseases (2014) - PMID: 24700657
Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer's Disease
Westmann et al., Plos One (2014) - PMID: 24804776
Identification and HLA-Tetramer-Validation of Human CD4+ and CD8+ T Cell Responses Against HCMV Proteins IE1 and IE2
Braendstrup et al., PLOS ONE (2014) - PMID: 24760079
Timing and Intensity of Exposure to Interferon‐gamma Critically Determines the Function of Monocyte‐derived Dendritic Cells
Kerkar et al., Immunology (2014) - PMID: 24678989
Day 3 Poly (I: C)-Activated Dendritic Cells Generated in CellGro for Use in Cancer Immunotherapy Trials are Fully Comparable to Standard Day 5 DCs
Truxova et al., Immunology Letters (2014) - PMID: 24726860
Immunologic Response to the Survivin-Derived Multi-Epitope Vaccine EMD640744 in Patients with Advanced Solid Tumors
Lennerz er al., Cancer Immunol Immunothert (2014) - PMID: 24487961
Miniaturized and High Throughput Assays for Analysis of T-Cell Responses Specific for Opportunistic Pathogens and HIV
Li Pira et al., Clin Vaccine Immunol. (2014) - PMID: 24477854
The Allo- and Viral-Specific Immunosuppressive Effect of Belatacept, but Not Tacrolimus, Attenuates with Progressive T Cell Maturation
Xu er al., Am. J. Transplant (2014) - PMID: 24472192
Statistical Methods for the Assessment of EQAPOL Proficiency Testing: ELISpot, Luminex, and Flow Cytometry
Rountree et al., J. Immunol Methods (2014) - PMID: 24456626
Evaluation of Cytomegalovirus (CMV)-Specific T-Cell Immunity for the Assessment of the Risk of Active CMV Infection in Non-Immunosuppressed Surgical and Trauma Intensive Care Unit Patients
Clari et al., J. Med Virol. (2013) - PMID: 23868746
Immunotherapeutic Strategies to Prevent and Treat Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation
Gerdemann et al. (2013) - PMID: 23152545
Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8+ T Cells That Is Associated with Lower Viral Load
Peña et al., AIDS Res Hum Retroviruses (2013) - PMID: 24180338
Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor Cell Products Ex Vivo and Safely Transferred to Stem Cell Transplantation Recipients to Facilitate Imm
Clancy et al., Biology Blood Marrow Transplant (2013) - PMID: 23380344
Broad and Potent Cellular and Humoral Immune Responses After a Second Late HIV-Modified Vaccinia Virus Ankara Vaccination in HIV-DNA-Primed and HIV-Modified Vaccinia Virus Ankara-Boosted Swedish Vaccinees
Nilsson et al., AIDS Res Hum Retroviruses (2013) - PMID: 24090081
Combining Next-Generation Sequencing and Immune Assays: A Novel Method for Identification of Antigen-Specific T Cells
Klinger et al., PLoS One (2013) - PMID: 24069285
Single-Cell Level Response of HIV-Specific and Cytomegalovirus-Specific CD4 T Cells Correlate With Viral Control in Chronic HIV-1 Subtype A Infection
Eller et al., J. Acquir Immune Defic Syndr (2012) - PMID: 22580564
A New Antigen Scanning Strategy for Monitoring HIV-1 Specific T-cell Immune Responses
Manati et al., Journal of Immunological Methods (2012) - PMID: 21963950
Polyfunctional T Cells Accumulate in Large Human Cytomegalovirus-Specific T Cell Responses
Lachmann et al., J. Virol. (2012) - PMID: 22072753
Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans
Eller et al., PLoS ONE (2011) - PMID: 21526194
Correlating Cellular and Molecular Signatures of Mucosal Immunity that Distinguish HIV Controllers from Non-Controllers
Loke et al., Blood (2011) - PMID: 20160163
Generation of a Multipathogen-Specific T-cell Product for Adoptive Immunotherapy Based on Activation-Dependent Expression of CD154
Khanna et al., Blood (2011) - PMID: 21642594
A Panel of Human Cell-Based Artificial APC Enables the Expansion of Long-Lived Antigen-Specific CD4+ T Cells Restricted by Prevalent HLA-DR Alleles
Butler et al., Int. Immunol. (2010) - PMID: 21059769
AdCD40L Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial
Malmström et al., Clin. Cancer Res. (2010) - PMID: 20448220
Intense Antiextracellular Adaptive Immune Response to Human Cytomegalovirus in Very Old Subjects with Impaired Health and Cognitive and Functional Status
Vescovini et al., J. Immunol. (2010) - PMID: 20173031
Human Late Memory CD8+ T Cells Have a Distinct Cytokine Signature Characterized by CC Chemokine Production without IL-2 Production
St. Johns et al., J. Immunol. (2009) - PMID: 19841187
The Transfer of Adaptive Immunity to Cytomegalovirus (CMV) During Hematopoietic Stem Cell Transplantation is Dependent on the Specificity and Phenotype of CMV-Specific T Cells in the Donor
Scheinberg et al., Blood (2009) - PMID: 19776383
T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28null T Cells
Fasth et al., J. Immunol. (2009) - PMID: 19752224
Identification and Characterization of IL-10/IFN-gamma-Producing Effector-Like T cells with Regulatory Function in Human Blood
Haringer et al., J. Exp. Med. (2009) - PMID: 19414553
Enumeration of Cytomegalovirus-Specific Interfering CD8+ and CD4+ T Cells Early After Allogeneic Stem Cell Transplantation May Identify Patients at Risk of Active Cytomegalovirus Infection
Solano et al., Haematologica (2008) - PMID: 18603553
Clonotype Analysis of Cytomegalovirus-Specific Cytotoxic T Lymphocytes
Babel et al., JASN Express (2008) - PMID: 18799721
Type I IFN-Induced, NKT Cell-Mediated Negative Control of CD8 T Cell Priming by Dendritic Cells1
Bochtler et al., The Journal of Immunology (2008) - PMID: 18641299
Prophylactic Infusion of Cytomegalovirus Specific Cytotoxic T-lymphocytes Stimulated with Ad5f35pp65 Gene Modified Dendritic Cells Following Allogeneic Haemopoietic Stem Cell Transplantation
Micklethwaite et al., Blood (2008) - PMID: 18768783
Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects
Viscovini et al., J Immunol. (2007) - PMID: 17785869
Longitudinal Assessment of Cytomegalovirus (CMV)–Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV disease
La Rosa et al., The Journal of Infectious Diseases (2007) - PMID: 17262704
No Evidence for Circulating HuD-Specific CD8+ T Cells in Patients with Paraneoplastic Neurological Syndromes and Hu Antibodies
De Beukelaar et al., Cancer Immunol Immunother (2007) - PMID: 17597332
The T Cell Response to Persistent Herpes Virus Infections in Common Variable Immunodeficiency
Raeiszadeh et al., British Society for Immunology, Clinical and Experimental Immunology (2006) - PMID: 17034575
Monoculture-Derived T lymphocytes Specific for Multiple Viruses Expand and Produce Clinically Relevant Effects in Immunocompromised Individuals
Leen et al., Nature Medicine (2006) - PMID: 16998485
Direct Access to CD4+ T Cells Specific for Defined Antigens According to CD154 Expression
Frentsch et al., Nat Med. (2005) - PMID: 16186818
HLA Type-Independent Generation of Antigen-Specific T Cells for Adoptive Immunotherapy
Hammer et al., Eur. J. Immunol. (2005) - PMID: 16468975

PepMix™ Peptide Pools - Control Pools